| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/05/2012 | US20120004227 Cyclohexane derivative having npy y5 receptor antagonism |
| 01/05/2012 | US20120004226 Modulators of Muscarinic Receptors |
| 01/05/2012 | US20120004223 Compounds, compositions and methods for reducing lipid levels |
| 01/05/2012 | US20120004220 Selective androgen receptor modulators (sarms) and uses thereof |
| 01/05/2012 | US20120004218 Novel tetrahydro-quinoline derivatives |
| 01/05/2012 | US20120004216 Modulators of atp-binding cassette transporters |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004213 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004206 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/05/2012 | US20120004200 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/05/2012 | US20120004198 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 01/05/2012 | US20120004192 Use of lactulose in the treatment of autism |
| 01/05/2012 | US20120004187 Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004171 Novel therapies for chronic renal failure |
| 01/05/2012 | US20120004168 Exendins and exendin agonist analogs to regulate gastrointestinal motility |
| 01/05/2012 | US20120004167 (2-aryloxyacetylamino) phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004166 Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| 01/05/2012 | US20120004165 Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| 01/05/2012 | US20120004164 Organic compounds |
| 01/05/2012 | US20120004163 Nutritional composition for infants |
| 01/05/2012 | US20120004162 Methods of Treating an Overweight or Obese Subject |
| 01/05/2012 | US20120003340 Compositions and methods for detoxification and cancer prevention |
| 01/05/2012 | US20120003339 Compositions and methods for controlling blood glucose levels |
| 01/05/2012 | US20120003337 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 01/05/2012 | US20120003335 Constitutive androstane receptor (car) as a therapeutic target for obesity and type two diabetes |
| 01/05/2012 | US20120003312 Multilayer Minitablets with Different Release Rates |
| 01/05/2012 | US20120003302 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure |
| 01/05/2012 | US20120003242 Modulating pdx-1 with pcif1, methods and uses thereof |
| 01/05/2012 | US20120003240 Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (III) |
| 01/05/2012 | US20120003239 Enterovirus Vaccines for Preventing and Treating Type 1 Diabetes (II) |
| 01/05/2012 | US20120003238 Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I) |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003233 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 01/05/2012 | US20120003226 Methods for treating or preventing il-1beta related diseases |
| 01/05/2012 | US20120003224 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2 |
| 01/05/2012 | US20120003222 Fzd8 extracellular domains and fzd8 extracellular domain fusion molecules and treatments using same |
| 01/05/2012 | US20120003216 Fgf21 mutants and uses thereof |
| 01/05/2012 | US20120003202 Cns delivery of therapeutic agents |
| 01/05/2012 | US20120003186 Method for dedifferentiating adipose tissue stromal cells |
| 01/05/2012 | US20120003175 Therapeutic uses of mastic gum fractions |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 01/05/2012 | DE102010030688A1 Substituierte Dicyanopyridine und ihre Verwendung Substituted dicyanopyridines and their use |
| 01/05/2012 | DE102010025725A1 Preparation of an extract from Cinnamomum osmophloeum Kaneh leaves, useful e.g. for treating dyslipidemia, comprises extracting Cinnamomum osmophloeum Kaneh leaves in hot water |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2803660A1 Compound for inhibiting type 5 phosphodiesterase and preparation method thereof |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803478A1 Novel tetrahydroquinoline derivatives |
| 01/05/2012 | CA2803031A1 A reconstituted high density lipoprotein formulation and production method thereof |
| 01/05/2012 | CA2802288A1 Fused heterocyclic compounds as ion channel modulators |
| 01/04/2012 | EP2402455A1 Process for producing carotenoid |
| 01/04/2012 | EP2402431A1 Agent for prevention or amelioration of obesity |
| 01/04/2012 | EP2402372A2 Therapeutic agent |
| 01/04/2012 | EP2402342A1 Pharmaceutical composition for treatment of 2 type dabetes |
| 01/04/2012 | EP2402327A1 Acetamide compounds as glucokinase activators, their process and medicinal applications |
| 01/04/2012 | EP2402326A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 01/04/2012 | EP2402027A1 Enterovirus vaccines for preventing or treating type 1 diabetes (I) |
| 01/04/2012 | EP2402018A1 Magnesium oxide fine granules |
| 01/04/2012 | EP2402002A1 Compositions of an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 01/04/2012 | EP2401266A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them |
| 01/04/2012 | EP2400840A1 Liquid statin formulations |
| 01/04/2012 | EP2400839A1 Prebiotic formulations and methods of use |
| 01/04/2012 | EP2334687B1 Dioxa-bicyclo[3.2.1.]octane-2,3,4-triol derivatives |
| 01/04/2012 | EP1986645B1 Glucokinase activators |
| 01/04/2012 | EP1562604B1 Prostaglandin compounds for the treatment of obesity |
| 01/04/2012 | CN1891242B Production process for removing polycyclic aromatic hydrocarbons from ginkgo leaf extract |
| 01/04/2012 | CN1740195B Polypeptide gapM1 and its prepn process |
| 01/04/2012 | CN1449746B Soft capsule containing trace element |
| 01/04/2012 | CN102307996A Compositions and methods for inhibiting expression of PTP1B genes |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307871A Isoindolinone and related analogs as sirtuin modulators |
| 01/04/2012 | CN102307861A Phenylimidazole compounds |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102307847A Indanyl compounds |
| 01/04/2012 | CN102307587A Use of APL-type peptide for treating intestinal inflammatory diseases and type 1 diabetes |
| 01/04/2012 | CN102307577A Pharmaceutical composition comprising an SGLT2 inhibitor, a DPP-IV inhibitor and a third antidiabetic agent, and uses thereof |
| 01/04/2012 | CN102304179A GLP-1 and exendin related invention |
| 01/04/2012 | CN102304166A Tanshinone derivative and pharmaceutical composition thereof as well as application of tanshinone derivative in pharmacy |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 01/04/2012 | CN102304103A Fenofibrate acid salt, preparation method, pharmaceutical composition and application |
| 01/04/2012 | CN102302769A Blood-sugar-reducing composition and application thereof |
| 01/04/2012 | CN102302755A Chinese herbal medicine foot bath preparation for treating diabetes mellitus |
| 01/04/2012 | CN102302689A Chinese medicinal composition capable of reducing blood sugar, and preparation method and application of Chinese medicinal composition |
| 01/04/2012 | CN102302684A Radix notoginseng tablets for promoting blood circulation |
| 01/04/2012 | CN102302673A Traditional Chinese medicine compound preparation for preventing and treating diabetic nephropathy (DN) |
| 01/04/2012 | CN102302644A Traditional Chinese medicine for treating diabetic peripheral neuropathy and preparation method thereof |
| 01/04/2012 | CN102302617A Traditional Chinese medicinal preparation for invigorating stomach, relaxing bowel and reducing blood fat and preparation method thereof |
| 01/04/2012 | CN102302614A Compound sea-cucumber tea-polyphenol capsules and preparation method thereof |
| 01/04/2012 | CN102302592A Preparation technology and purpose of citrus grandis peel flavones |
| 01/04/2012 | CN102302581A Chinese patent medicine for reducing hyperlipidemia |
| 01/04/2012 | CN102302579A Medicament for treating obesity |